Complexo Hospitalario Universitario de Santiago
Centro de atención
University of Surrey
Guildford, Reino UnidoPublicacións en colaboración con investigadores/as de University of Surrey (12)
2023
-
Genetic and immune landscape evolution in MMR-deficient colorectal cancer
Journal of Pathology
2022
-
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study
Intensive Care Medicine, Vol. 48, Núm. 6, pp. 690-705
-
Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)
Intensive Care Medicine
2019
-
Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)
Nature Communications
-
Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: Biochemical markers associated with emerging clinical phenotypes and molecular endotypes
Current Opinion in Rheumatology, Vol. 31, Núm. 1, pp. 80-89
2018
-
Adipokines and inflammation: is it a question of weight?
British Journal of Pharmacology, Vol. 175, Núm. 10, pp. 1569-1579
-
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications, Vol. 9, Núm. 1
-
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications, Vol. 9, Núm. 1
2017
-
Progranulin as a biomarker and potential therapeutic agent
Drug Discovery Today, Vol. 22, Núm. 10, pp. 1557-1564
-
Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice?
Best Practice and Research: Clinical Rheumatology, Vol. 31, Núm. 5, pp. 705-720
-
The role of metabolism in the pathogenesis of osteoarthritis
Nature Reviews Rheumatology, Vol. 13, Núm. 5, pp. 302-311
2015
-
The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases
Biomarkers, Vol. 20, Núm. 8, pp. 565-571